Analysts Tie Broadcom Upside to IPOs, Upgrade Rivian, Downgrade Moderna
Photo: TokenPost
Analysts offered sharply different views on three major U.S. stocks this week, with D.A. Davidson tying conditional Broadcom upside to IPO plans, Jefferies upgrading Rivian and William Blair downgrading Moderna. D.A. Davidson said Broadcom (AVGO) could have significant upside if Anthropic and OpenAI pursue IPOs and raise capital. The firm argued that Broadcom’s valuation reflects a low likelihood of those deals. Jefferies moved Rivian (RIVN) to a Buy rating, pointing to what it viewed as an attractive entry point, automotive gross margins moving closer to positive territory and plans to scale the R2 model.
Source: TokenPost
